期刊文献+
共找到103篇文章
< 1 2 6 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
7
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
孟鲁司特钠颗粒联合阿奇霉素注射液对小儿肺炎支原体肺炎的治疗效果分析
8
作者 吕丹 刘溢斌 黄晨峰 《中外医疗》 2024年第20期17-20,共4页
目的分析孟鲁司特钠颗粒联合阿奇霉素注射液对小儿肺炎支原体肺炎的治疗效果。方法随机选取2022年11月—2023年11月金沙县人民医院收治的120例小儿肺炎支原体肺炎患儿为研究对象。依照随机抽签分组法分为参照组与观察组,每组60例。两组... 目的分析孟鲁司特钠颗粒联合阿奇霉素注射液对小儿肺炎支原体肺炎的治疗效果。方法随机选取2022年11月—2023年11月金沙县人民医院收治的120例小儿肺炎支原体肺炎患儿为研究对象。依照随机抽签分组法分为参照组与观察组,每组60例。两组均进行常规对症治疗,在此基础上,参照组给予阿奇霉素注射液治疗,观察组给予孟鲁司特钠颗粒联合阿奇霉素注射液治疗。比较两组的C反应蛋白含量、症状好转时间、治疗效果、不良反应情况、X线影像学图像表现。结果治疗前,两组的C反应蛋白含量对比,差异无统计学意义(P>0.05);治疗后,观察组的C反应蛋白含量低于参照组,差异有统计学意义(P<0.05)。观察组的症状好转时间短于参照组,差异有统计学意义(P<0.05)。观察组的治疗有效率为98.33%,高于参照组的86.67%,差异有统计学意义(χ^(2)=4.324,P=0.038)。两组的不良反应总发生率比较,差异无统计学意义(P>0.05)。观察组的X线影像学图像表现优于参照组,差异有统计学意义(P<0.05)。结论应用孟鲁司特钠颗粒联合阿奇霉素注射液治疗小儿肺炎支原体肺炎,可以提高疗效,改善X线影像学图像表现,降低C反应蛋白含量,加快患儿恢复,值得借鉴。 展开更多
关键词 孟鲁司特钠颗粒 阿奇霉素注射液 小儿肺炎支原体肺炎 症状好转时间 治疗效果
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
9
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
10
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
孟鲁司特钠片联合布地奈德雾化吸入治疗小儿哮喘的临床效果及对患儿外周血嗜酸性粒细胞指标的影响研究 被引量:3
11
作者 邹莉 朱春梅 《中国现代药物应用》 2023年第14期104-107,共4页
目的探究小儿哮喘患儿采取孟鲁司特钠片联合布地奈德雾化吸入治疗后的临床效果和外周血嗜酸性粒细胞(EOS)指标的变化情况。方法96例小儿哮喘患儿,依据电脑随机表法分为常规组和联合组,各48例。常规组实施布地奈德雾化吸入治疗,联合组实... 目的探究小儿哮喘患儿采取孟鲁司特钠片联合布地奈德雾化吸入治疗后的临床效果和外周血嗜酸性粒细胞(EOS)指标的变化情况。方法96例小儿哮喘患儿,依据电脑随机表法分为常规组和联合组,各48例。常规组实施布地奈德雾化吸入治疗,联合组实施孟鲁司特钠片联合布地奈德雾化吸入治疗。对比两组治疗效果、不良反应发生情况、肺功能指标[第1秒用力呼气容积(FEV1)、用力肺活量(FVC)]及EOS水平。结果联合组治疗总有效率97.92%高于常规组的81.25%,差异有统计学意义(P<0.05)。治疗后,两组FEV1、FVC均高于本组治疗前,EOS水平低于本组治疗前,且联合组FEV1(2.01±0.11)L、FVC(3.01±0.11)L高于常规组的(1.50±0.10)、(2.30±0.07)L,EOS水平(0.19±0.04)×10^(9)/L低于常规组的(0.51±0.10)×10^(9)/L,差异均有统计学意义(P<0.05)。联合组不良反应发生率4.17%明显低于常规组的22.92%,差异有统计学意义(P<0.05)。结论孟鲁司特钠片联合布地奈德雾化吸入治疗小儿哮喘疗效显著,患儿EOS水平降低,不良反应发生率低,可推广。 展开更多
关键词 孟鲁司特钠片 布地奈德 小儿哮喘 治疗效果 外周血嗜酸性粒细胞
下载PDF
通窍鼻炎颗粒联合孟鲁斯特治疗儿童慢性鼻窦炎的疗效观察 被引量:3
12
作者 史雅楠 苏金柱 +1 位作者 王娟 耿江桥 《中国中西医结合耳鼻咽喉科杂志》 2023年第3期175-178,199,共5页
目的 观察通窍鼻炎颗粒联合孟鲁斯特治疗小儿慢性鼻窦炎的疗效。方法 选取2020年5月~2021年5月我院收治的儿童慢性鼻窦炎387例,随机分为对照组(例=194)和观察组(例=193),对照组予以安慰剂治疗,研究组予以通窍鼻炎颗粒联合孟鲁斯特治疗,... 目的 观察通窍鼻炎颗粒联合孟鲁斯特治疗小儿慢性鼻窦炎的疗效。方法 选取2020年5月~2021年5月我院收治的儿童慢性鼻窦炎387例,随机分为对照组(例=194)和观察组(例=193),对照组予以安慰剂治疗,研究组予以通窍鼻炎颗粒联合孟鲁斯特治疗,比较分析二组的疗效差异以及细胞因子表达水平差异。结果 与对照组相比,研究组有效率较高(P<0.05),不良反应较少(P<0.05);研究组血清IL-4、IFN-γ及TNF-α水平较低(P<0.05);研究组鼻塞、鼻漏、嗅觉障碍及头面部疼痛评分较低(P<0.05),VAS评分及Lund-Kennedy评分较低(P<0.05),生活质量较高(P<0.05)。结论 联合应用通窍鼻炎颗粒与孟鲁斯特治疗儿童慢性鼻窦炎效果显著,可有效降低炎症因子水平,减轻临床症状。 展开更多
关键词 儿童慢性鼻窦炎 通窍鼻炎颗粒 孟鲁斯特 疗效观察
下载PDF
布地奈德联合孟鲁司特钠治疗小儿咳嗽变异性哮喘的疗效观察 被引量:4
13
作者 杨红梅 《中国现代药物应用》 2023年第2期133-135,共3页
目的分析小儿咳嗽变异性哮喘(CVA)的特点,评价布地奈德联合孟鲁司特钠治疗的预后效果。方法80例小儿咳嗽变异性哮喘患儿,随机分为对照组及观察组,每组40例。对照组患儿采取布地奈德治疗,观察组患儿采取布地奈德联合孟鲁司特钠治疗。比... 目的分析小儿咳嗽变异性哮喘(CVA)的特点,评价布地奈德联合孟鲁司特钠治疗的预后效果。方法80例小儿咳嗽变异性哮喘患儿,随机分为对照组及观察组,每组40例。对照组患儿采取布地奈德治疗,观察组患儿采取布地奈德联合孟鲁司特钠治疗。比较两组患儿的临床疗效,治疗前后的肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积(FEV1)]、炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-4(IL-4)]水平。结果观察组患儿的总有效率95.00%高于对照组的70.00%,差异具有统计学意义(P<0.05)。治疗前,两组患儿的FVC、FEV1、TNF-α、IL-4水平比较,差异无统计学意义(P>0.05);治疗后,观察组患儿的FVC(3.30±1.10)L、FEV1(2.50±0.50)L高于对照组的(2.50±0.80)、(2.02±0.50)L,TNF-α(0.53±0.10)μg/L、IL-4(56.20±8.80)ng/L低于对照组的(0.90±0.12)μg/L、(95.50±10.50)ng/L,差异具有统计学意义(P<0.05)。结论小儿咳嗽变异性哮喘患儿在布地奈德联合孟鲁司特钠的协同治疗下,能够有效提升治疗效果,减轻患儿的炎症因子水平,改善肺功能。 展开更多
关键词 布地奈德 孟鲁司特钠 小儿咳嗽变异性哮喘 炎症因子水平 肺功能 治疗效果
下载PDF
孟鲁司特钠对呼吸道合胞病毒毛细支气管炎患儿的临床疗效及对免疫功能、预后复发哮喘的影响 被引量:2
14
作者 覃旭 黄智伟 方素 《临床和实验医学杂志》 2023年第6期647-651,共5页
目的探究孟鲁司特钠对呼吸道合胞病毒(RSV)毛细支气管炎患儿的临床疗效及对免疫功能、预后复发哮喘的影响。方法回顾性选取2019年8月至2021年8月在广西医科大学附属武鸣医院接受治疗的RSV毛细支气管炎患儿110例,根据其治疗方式进行分组... 目的探究孟鲁司特钠对呼吸道合胞病毒(RSV)毛细支气管炎患儿的临床疗效及对免疫功能、预后复发哮喘的影响。方法回顾性选取2019年8月至2021年8月在广西医科大学附属武鸣医院接受治疗的RSV毛细支气管炎患儿110例,根据其治疗方式进行分组。其中在常规基础上联合孟鲁司特钠治疗的55例患儿计为观察组,采用常规治疗的55例患儿计为对照组。评估两组患儿的治疗疗效,比较两组患儿的治疗前以及治疗后1周血清嗜酸粒细胞阳离子蛋白(ECP)、半胱氨酰白三烯(CysLTs)、尿白三烯E4(LTE4)、白细胞介素-8(IL-8)水平,观察两组患儿糖皮质激素、β-受体激动剂应用情况,以及咳嗽、哮喘消失时间、住院时间。观察两组患儿治疗后不良反应的发生情况和哮喘复发情况。结果观察组总有效率为96.36%,高于对照组的85.45%,差异有统计学意义(P<0.05)。治疗后,两组血清ECP、CysLTs、LTE4、IL-8水平均较治疗前下降,观察组以上指标水平为(33.07±5.41)μg/L、(16.62±5.17)ng/L、(68.36±10.22)kU/L、(41.05±8.63)μg/mL,均低于对照组[(40.24±9.38)μg/L、(19.58±3.42)ng/L、(76.04±1.55)kU/L、(48.24±12.05)μg/mL],差异均有统计学意义(P<0.05)。两组患儿的糖皮质激素使用百分比比较,差异无统计学意义(P>0.05),但观察组患儿应用β-受体激动剂占比为25.45%,较对照组(45.45%)高,且咳嗽/哮喘消失时间和住院时间为(6.05±1.53)、(5.04±1.19)、(7.04±2.18)d,短于对照组[(8.24±0.68)、(6.60±1.88)、(8.21±1.95)d],差异均有统计学意义(P<0.05)。观察组不良反应总发生率为27.27%,对照组为16.36%,差异无统计学意义(P>0.05);观察组随访6个月内再次哮喘发生率分别为14.55%,较对照组(30.91%)低,差异有统计学意义(P<0.05)。结论孟鲁司特钠可提高RSV毛细支气管炎患儿临床治疗疗效,增强其免疫功能、缓解炎症,降低预后复发哮喘概率。 展开更多
关键词 呼吸道合胞病毒毛细支气管炎 孟鲁司特钠 治疗疗效 预后复发哮喘 免疫功能
下载PDF
孟鲁司特钠联合布地奈德福莫特罗治疗CVA的疗效及对肺功能和炎性指标的影响 被引量:1
15
作者 钟林园 《临床合理用药杂志》 2023年第8期12-14,18,共4页
目的观察孟鲁司特钠联合布地奈德福莫特罗治疗咳嗽变异性哮喘(CVA)的疗效及对肺功能和炎性指标的影响。方法选取2018年8月—2020年8月江西省龙南市第一人民医院收治的CVA患者80例,采用掷硬币法随机分为观察组和对照组,每组40例。对照组... 目的观察孟鲁司特钠联合布地奈德福莫特罗治疗咳嗽变异性哮喘(CVA)的疗效及对肺功能和炎性指标的影响。方法选取2018年8月—2020年8月江西省龙南市第一人民医院收治的CVA患者80例,采用掷硬币法随机分为观察组和对照组,每组40例。对照组在常规治疗基础上给予布地奈德福莫特罗治疗,观察组在对照组基础上给予孟鲁司特钠治疗,2组患者均治疗1个月。比较2组患者临床疗效、治疗前后肺功能及血清炎性指标。结果治疗1个月后,观察组患者总有效率为97.50%,高于对照组的80.00%(χ^(2)=4.507,P=0.013);2组患者用力肺活量(FVC)、第1秒用力呼气容积(FEV 1)及FEV 1/FVC均高于治疗前,且观察组高于对照组(P<0.05或P<0.01);2组患者白介素-5(IL-5)、肿瘤坏死因子-α(TNF-α)及超敏C反应蛋白(hs-CRP)水平均低于治疗前,且观察组低于对照组(P均<0.01)。结论孟鲁司特钠联合布地奈德福莫特罗治疗CVA效果较好,可控制炎性指标,改善肺功能,值得推广应用。 展开更多
关键词 咳嗽变异性哮喘 孟鲁司特钠 布地奈德福莫特罗 治疗效果 肺功能 炎性指标
下载PDF
The role of drug utilization evaluation in medical sciences
16
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
孟鲁司特钠联合复方异丙托溴铵治疗儿童哮喘疗效及对患儿呼吸功能的影响
17
作者 苏建梅 刘爱玲 孙永明 《当代医学》 2023年第10期65-68,共4页
目的探讨孟鲁司特钠联合复方异丙托溴铵治疗儿童哮喘的疗效及对患儿呼吸功能的影响。方法选取2022年1月至2022年12月本院收治的100例小儿哮喘急性发作患儿作为研究对象,随机分为对照组与观察组,每组50例。对照组单一应用复方异丙托溴铵... 目的探讨孟鲁司特钠联合复方异丙托溴铵治疗儿童哮喘的疗效及对患儿呼吸功能的影响。方法选取2022年1月至2022年12月本院收治的100例小儿哮喘急性发作患儿作为研究对象,随机分为对照组与观察组,每组50例。对照组单一应用复方异丙托溴铵治疗,观察组在对照组基础上给予孟鲁司特钠治疗,比较两组症状消失时间、临床疗效、治疗前后气道功能[呼气高峰流量(PEF)、第1秒用力呼气容积占用力肺活量比值(FEV_(1)/FVC)、达峰容积比(VPEF/VE)、达峰时间比(TPTEF/TE)]、治疗前后炎症因子[白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、C反应蛋白(CRP)]水平及不良反应发生情况。结果观察组哮鸣音、咳痰、喘息、湿罗音消失时间均短于对照组(P<0.05);观察组治疗总有效率为100.00%,明显高于对照组的82.00%,差异有统计学意义(P<0.05)。治疗前,两组CRP、IL-4、IL-6、IL-10水平比较差异无统计学意义;治疗后,两组CRP、IL-4、IL-6水平均低于治疗前,IL-10水平高于治疗前,且观察组CRP、IL-4、IL-6水平均低于对照组,IL-10水平高于对照组,差异有统计学意义(P<0.05)。治疗前,两组PEF、FEV_(1)/FVC、VPEF/VE、TPTEF/TE比较差异无统计学意义;治疗后,两组PEF、FEV_(1)/FVC、VPEF/VE、TPTEF/TE均大于治疗前,且观察组大于对照组,差异有统计学意义(P<0.05)。两组治疗期间均无不良反应发生。结论小儿哮喘急性发作时采用复方异丙托溴铵、孟鲁司特钠联合治疗效果显著,促进改善临床症状及气道功能,有效控制炎症因子水平,用药安全性好,应用价值较高。 展开更多
关键词 小儿哮喘 急性发作 复方异丙托溴铵 孟鲁司特钠 治疗效果 气道功能
下载PDF
过敏性紫癜患儿应用孟鲁司特钠联合氯雷他定的治疗效果分析
18
作者 佟杰 于珍梅 王照月 《系统医学》 2023年第20期146-149,共4页
目的评估孟鲁司特钠联合氯雷他定治疗小儿过敏性紫癜的有效性。方法选择2020年1月—2023年1月期间烟台市北海医院收治的70例过敏性紫癜患儿作为研究对象,根据随机数表法分为对照组、观察组,每组35例。对照组采用孟鲁司特钠治疗,观察组... 目的评估孟鲁司特钠联合氯雷他定治疗小儿过敏性紫癜的有效性。方法选择2020年1月—2023年1月期间烟台市北海医院收治的70例过敏性紫癜患儿作为研究对象,根据随机数表法分为对照组、观察组,每组35例。对照组采用孟鲁司特钠治疗,观察组采用孟鲁司特钠联合氯雷他定治疗。比较两组治疗总有效率、炎症因子水平、症状消失时间、不良反应发生率。结果观察组总有效率为97.14%,高于对照组的71.43%,差异有统计学意义(χ^(2)=8.737,P<0.05)。治疗后观察组血清骨桥蛋白、肿瘤坏死因子-α、白细胞介素-6水平均低于对照组,差异有统计学意义(P<0.05)。观察组腹痛、皮肤紫癜、恶心呕吐、关节肿痛症状消失时间均短于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论孟鲁司特钠联合氯雷他定治疗小儿过敏性紫癜具有显著效果,可以增强疗效,降低炎症反应,并且缩短患儿临床症状消失时间。 展开更多
关键词 孟鲁司特钠 氯雷他定 小儿过敏性紫癜 不良反应 治疗有效率
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
19
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
孟鲁司特治疗老年稳定期慢性阻塞性肺疾病患者的疗效分析 被引量:10
20
作者 赵恬 顾亮 +1 位作者 杜坚宗 钦光跃 《中国临床药理学与治疗学》 CAS CSCD 2013年第1期66-70,共5页
目的:评价孟鲁司特治疗老年稳定期中重度慢性阻塞性肺疾病(COPD)患者的疗效及安全性。方法:60例男性稳定期中重度COPD患者随机分为治疗组和对照组,在规则吸入布地奈德联合福莫特罗(信必可都保)的基础上,治疗组加服孟鲁司特,疗程6个月。... 目的:评价孟鲁司特治疗老年稳定期中重度慢性阻塞性肺疾病(COPD)患者的疗效及安全性。方法:60例男性稳定期中重度COPD患者随机分为治疗组和对照组,在规则吸入布地奈德联合福莫特罗(信必可都保)的基础上,治疗组加服孟鲁司特,疗程6个月。比较两组患者治疗前后基础呼吸困难指数(BDI)、圣乔治呼吸问卷(SGRQ)评分、肺功能、诱导痰细胞分类及白三烯B4(LTB4)水平。结果:47例患者完成试验,期间未发生孟鲁司特相关严重药物不良反应。两组患者经治疗后BDI均升高,SGRQ评分及诱导痰中性粒细胞百分比均下降(P<0.05),但肺功能均无明显改善(P>0.05)。与对照组相比,治疗组患者诱导痰中嗜酸性粒细胞百分比下降,且BDI、SGRQ评分、诱导痰LTB4水平的改善作用更明显,两组改善率差异有统计学意义(P<0.05)。结论:孟鲁司特作为老年稳定期中重度COPD患者的补充治疗安全有效。 展开更多
关键词 盂鲁司特 白三烯受体拮抗剂 慢性阻塞性肺疾病 疗效
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部